Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy? Flores JM, Vertosick E, Jenkins LC, Cooper J, et al. J Urol 2024;211:400-406.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Flores JM, Vertosick E, Jenkins LC, Cooper J, et al. Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy? J Urol 2024;211:400-406.
PMID: 38194487